Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Aesthet Surg J
; 41(11): 1338, 2021 Oct 15.
Article
en En
| MEDLINE
| ID: mdl-33739363
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
Aesthet Surg J
Año:
2021
Tipo del documento:
Article